Chapter 43 Motorcortical excitability after electroconvulsive therapy in patients with major depressive disorder

Supplements to Clinical Neurophysiology

Volumn 56, Issue C, 2003, Pages 433-440

  Bajbouj, Malek ^a   Gallinat, Jurgen ^a   Lang, Undine E ^a   Neu, Peter ^a   Niehaus, Ludwig ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 13144275159     PISSN: 1567424X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-424X(09)70246-6     Document Type: Article

References (32)

1. Bowden C.L. Introduction: the role of anticonvulsants as mood stabilizers. J. Clin. Psychiatry 62 Suppl. 14 (2001) 3-4
2. Cross J.A., and Horton R.W. Effects of chronic oral administration of the antidepressants, desmethylimipramine and zimelidine on rat cortical GABA-B binding sites: a comparison with 5-HT2 binding site changes. Br. J. Pharmacol. 93 (1988) 331-336
3. Di Lazzaro V., Oliviero A., Meglio M., Cioni B., Tamburrini G., Tonali P., and Rothwell J.C. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin. Neurophysiol. 111 (2000) 794-799
4. Dickinson R., De Sousa S.L., Lieb W.R., and Franks N.P. Selective synaptic actions of thiopental and its enantiomers. Anesthesiology 96 (2002) 884-892
5. Fitzgerald P.B., Brown T.L., and Daskalakis Z.J. The application of transcranial magnetic stimulation in psychiatry and neuro-sciences research. Acta. Psychiatr. Scand. 105 (2002) 324-340
6. Green A.R. Changes in gamma-aminobutyric acid biochemistry and seizure threshold. Ann. NY Acad. Sci. 462 (1986) 105-119
7. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6 (1967) 278-296
8. Hanajima R., Ugawa Y., Terao Y., Sakai K., Furubayashi T., Machii K., and Kanazawa I. Paired-pulse magnetic stimulation of the human motor cortex: differences among I waves. J. Physiol., I 509 Pt. 2 (1998) 607-618
9. Herwig U., Brauer K., Connemann B., Spitzer M., and Schonfeldt-Lecuona C. Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation. Psychopharmacology (Berl) 164 (2002) 228-232
10. Inghilleri M., Berardelli A., Marchetti P., and Manfredi M. Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp. Brain Res. 109 (1996) 467-472
11. Janicak P.G., and Martis B. Strategies for treatment-resistant depression. Clin. Cornerstone 1 (1999) 58-71
12. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., Wroe S., Asselman P., and Marsden C.D. Corticocortical inhibition in human motor cortex. J. Physiol. 471 (1993) 501-519
13. Lipcsey A., Kardos J., Prinz G., and Simonyi M. Effect of electroconvulsive therapy on the GABA level in the cerebrospinal fluid. Psychiatr. Neurol. Med. Psychol. (Leipz) 38 (1986) 554-555
14. Lloyd K.G., Zivkovic B., Scatton B., Morselli P.L., and Bartholini G. The gabaergic hypothesis of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 13 (1989) 341-351
15. Maeda F., Keenan J.P., and Pascual-Leone A. Interhemispheric asymmetry of motor cortical excitability in major depression as measured by transcranial magnetic stimulation. Br. J. Psychiatry 177 (2000) 169-173
16. Nutt D.J., and Malizia A.L. New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br. J. Psychiatry 179 (2001) 390-396
17. Puri B.K., and Lewis S.W. Transcranial magnetic stimulation in psychiatric research. Br. J. Psychiatry 169 (1996) 675-677
18. Reis J., Tergau F., Hamer H.M., Muller H.H., Knake S., Fritsch B., Oertel W.H., and Rosenow F. Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia 43 (2002) 1149-1156
19. Roick H., von Giesen H.J., and Benecke R. On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects. Exp. Brain Res. 94 (1993) 489-498
20. Rothwell J.C. Physiological studies of electric and magnetic stimulation of the human brain. Electroencephalogr. Clin. Neurophysiol. 43 (1991) 29-35
21. Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28 (2003) 139-168
22. Sackeim H.A. The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J. ECT. 15 (1999) 5-26
23. Sanacora G., Mason G.F., and Krystal J.H. Impairment of GABAergic transmission in depression: new insights from neuroimaging studies. Crit. Rev. Neurobiol. 14 (2000) 23-45
24. Sanacora G., Mason G.F., Rothman D.L., Hyder F., Ciarcia J.J., Ostroff R.B., Berman R.M., and Krystal J.H. Increased Cortical GABA Concentrations in Depressed Patients Receiving ECT. Am. J. Psychiatry 160 (2003) 577-579
25. Sanger T.D., Garg R.R., and Chen R. Interactions between two different inhibitory systems in the human motor cortex. J. Physiol. 530 (2001) 307-317
26. Schmidt do Prado-Lima P.A., and Bacaltchuck J. Topiramate in treatment-resistant depression and binge-eating disorder. Bipolar Disord. 4 (2002) 271-273
27. Siebner H.R., Dressnandt J., Auer C., and Conrad B. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 21 (1998) 1209-1212
28. Sommer M., Dieterich A., Ruther E., Paulus W., and Wiltfang J. Increased transcranial magnetic motor threshold after ECT A case report. Eur Arch Psychiatry. Clin. Neurosci. 252 (2002) 250-252
29. Steele J.D., Glabus M.F., Shajahan P.M., and Ebmeier K.P. Increased cortical inhibition in depression: a prolonged silent period with transcranial magnetic stimulation (TMS). Psychol. Med. 30 (2000) 565-570
30. Werhahn K.J., Kunesch E., Noachtar S., Benecke R., and Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J. Physiol. 517 Pt. 2 (1999) 591-597
31. Wielosz M., Stelmasiak M., Ossowska G., and Kleinrok Z. Effects of electroconvulsive shock on central GABA-ergic mechanisms. Pol. J. Pharmacol. Pharm. 37 (1985) 113-122
32. Ziemann U., Lonnecker S., Steinhoff B.J., and Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp. Brain Res. 109 (1996) 127-135